ArticlePharmaceuticals (Basel, Switzerland)2019

Duvelisib: A 2018 Novel FDA-Approved Small Molecule Inhibiting Phosphoinositide 3-Kinases.

Daniel A Rodrigues et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.